Chanda Sanjay
AN2 Therapeutics, Inc. · Chief Development Officer
Chanda Sanjay is listed in public filings as officer: Chief Development Officer. This Chanda Sanjay insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include AN2 Therapeutics, Inc. (ANTX). Investors use Chanda Sanjay's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.
Latest Actions
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| $066k shares | OtherMar 19, 2026 | $1.1M66k shares | $17.28 | -- | |
| $058k shares | OtherMar 19, 2026 | $828.1K58k shares | $14.29 | -- | |
| $041.7k shares | OtherMar 19, 2026 | $274.8K41.7k shares | $6.60 | -- | |
| $258k66k shares | Grant / ExerciseMar 19, 2026 | $258.1K66k shares | $3.91 | -- | |
| $227k58k shares | Grant / ExerciseMar 19, 2026 | $226.6K58k shares | $3.91 | -- | |
| $163k41.7k shares | Grant / ExerciseMar 19, 2026 | $162.9K41.7k shares | $3.91 | -- |
Insider Trades History
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| --118.8k shares | Grant / ExerciseFeb 20, 2026 | Disclosure amount unavailable38k shares | -- | -- | |
| $80k77k shares | Grant / ExerciseFeb 20, 2026 | $80.1K77k shares | $1.04 | -- | |
| $77k75.8k shares | SellJan 6, 2026 | $6.0K6k shares | $1.01 | -- | |
| $82k81.8k shares | SellJan 5, 2026 | $3.3K3.3k shares | $1.00 | -- | |
| --80.1k shares | Grant / ExerciseFeb 26, 2025 | Disclosure amount unavailable50.3k shares | -- | -- | |
| $114k100.5k shares | Grant / ExerciseFeb 26, 2025 | $113.6K100.5k shares | $1.13 | -- | |
| $40k29.8k shares | SellJan 3, 2025 | $4.0K3k shares | $1.34 | -- |